XML 18 R7.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Cash flows from operating activities:    
Net income (loss) including non-controlling interests $ 129,376 $ (4,470,721)
Adjustments to reconcile net income (loss) including non-controlling interests to net cash provided by operating activities:    
Depreciation, depletion and amortization 112,581 272,885
Gain on extinguishment of debt 0 (83,867)
Gain on sale of properties (228,473) (11,652)
Impairment 5 4,828,575
Deferred income taxes 0 (262,459)
Derivative instruments 550,342 (243,064)
Equity-based compensation expenses 11,187 16,531
Non-cash reorganization items, net 0 49,758
Deferred financing costs amortization and other 18,811 19,041
Working capital and other changes:    
Change in accounts receivable, net (65,324) 168,749
Change in inventory 2,408 (6,206)
Change in prepaid expenses 4,509 (6,107)
Change in accounts payable, interest payable and accrued liabilities 118,942 (112,479)
Change in other assets and liabilities, net (9,618) (4,079)
Net cash provided by operating activities 644,746 154,905
Cash flows from investing activities:    
Capital expenditures (143,201) (291,776)
Acquisition deposit (74,500) 0
Proceeds from sale of properties 373,892 15,188
Costs related to sale of properties (2,785) 0
Derivative settlements (160,018) 224,223
Derivative modification (82,419) 0
Net cash used in investing activities (89,031) (52,365)
Cash flows from financing activities:    
Proceeds from revolving credit facilities 384,500 967,189
Principal payments on revolving credit facilities (884,500) (914,549)
Proceeds from issuance of senior unsecured notes 850,000 0
Repurchase of senior unsecured notes 0 (68,060)
Deferred financing costs (20,480) (172)
Proceeds from issuance of OMP common units, net of offering costs 86,592 0
Common control transaction costs (5,453) 0
Purchases of treasury stock (14,560) (2,651)
Dividends paid (102,123) 0
Distributions to non-controlling interests (20,443) (18,062)
Payments on finance lease liabilities (1,107) (1,989)
Proceeds from warrants exercised 241 0
Net cash provided by (used in) financing activities 272,667 (38,294)
Increase in cash, cash equivalents and restricted cash 828,382 64,246
Cash, cash equivalents and restricted cash:    
Beginning of period 20,226 20,019
End of period 848,608 84,265
Supplemental non-cash transactions:    
Change in accrued capital expenditures 13,014 (81,939)
Change in asset retirement obligations (389) 2,860
Note receivable from divestiture 2,900 0
Contingent consideration from Permian Basin Sale $ 32,860 $ 0